Experience with Quadruple Immunosuppressive Therapy in Renal Transplants

Birtch, 1971, A controlled clinical trial of antilymphocyte globulin in human renal allografts, Transplant Proc, 3, 762 Borel, 1976, Biological effects of cyclosporine A: A new antilymphatic agent, Agents Actions, 6, 465, 10.1007/BF01973261 Calne, 1978, Cyclosporine A in patients receiving renal allografts from cadaver donors, Lancet, 2, 1323, 10.1016/S0140-6736(78)91970-0 Calne, 1981, Cyclosporine A in cadaveric organ transplantation, Br Med J, 282, 934, 10.1136/bmj.282.6268.934 1986, A randomized clinical trial of cyclosporine in cadaveric renal transplantation: Analysis at three years, N Engl J Med, 314, 1219, 10.1056/NEJM198605083141904 Canafax, 1986, The effects of delayed function on recipients of cadaver renal allografts, Transplantation, 41, 177, 10.1097/00007890-198602000-00009 Carpenter, 1985, The impact of acute tubular necrosis on graft outcome in patients receiving cyclosporine, Transplant Proc, 17, 1282 Chang, 1981, Does OKT3 monoclonal antibody react with an antigen-recognition structure on human T-cells?, Proc Natl Acad Sci USA, 78, 1805, 10.1073/pnas.78.3.1805 Cho, 1985, The influence of acute tubular necrosis on kidney transplant survival, Transplant Proc, 17, 16 Condie, 1985, Efficacy of Minnesota antilymphoblast globulin in renal transplantation: A multicenter, placebo-controlled, prospective, randomized, double-blind study, Transplant Proc, 17, 1304 Cosimi, 1981, The clinical value of antilymphocyte antibodies, Transplant Proc, 13, 462 Davison, 1977, Relation of immediate post-transplant renal function to long-term function in cadaver kidney recipients, Transplantation, 23, 310, 10.1097/00007890-197704000-00003 Deierhoi, 1987, Quadruple immunosuppression in 305 consecutive cadaver renal allografts, Clin Transplant, 1, 71 Delmonico, 1987, The selective use of antilymphocyte serum for cyclosporine-treated patients with renal allograft dysfunction, Ann Surg, 206, 649, 10.1097/00000658-198711000-00016 1983, One-year follow-up of a multicenter trial, Lancet, 2, 986 Ferguson, 1982, Cyclosporine A in renal transplantation: A prospective randomized trial, Surgery, 92, 175 Friedman, 1984 Fries, 1987, Triple combination of low-dose cyclosporine, azathioprine, and steroids in first cadaver donor renal allografts, Transplant Proc, 19, 1911 Gonwa, 1986, Cyclosporine use in early graft dysfunction, Transplant Proc, 18, 104 Gordon, 1985, Cyclosporine-steroid combination therapy in 84 cadaveric renal transplants, Am J Kidney Dis, 5, 307, 10.1016/S0272-6386(85)80159-1 Hall, 1988, Comparison of three immunosuppressive regimens in cadaver renal transplantation: Long-term cyclosporine, short-term cyclosporine followed by azathioprine and prednisolone, and azathioprine and prednisolone without cyclosporine, N Engl J Med, 318, 1499, 10.1056/NEJM198806093182304 1985, Comparison of antilymphocyte globulin, Imuran, cyclosporine, and antilymphocyte globulin-cyclosporine therapy for cadaver renal transplantation, Transplant Proc, 17, 1201 Heil, 1984, Acute tubular necrosis of cadaver renal allografts does not correlate with organ sharing or preservation but portends a poorer prognosis for long-term graft survival, Transplant Proc, 16, 270 Henry, 1985, Beneficial effects of cyclosporine compared with azathioprine in cadaveric renal transplantation, Am J Surg, 150, 533, 10.1016/0002-9610(85)90431-3 Hoffmann RM, Stratta RJ, D’Alessandro AM, et al: Combined cold storage-perfusion preservation with a new synthetic perfusate. Transplantation, in press Johnson, 1988, A randomized trial comparing cyclosporine with antilymphoblast globulin-azathioprine for renal allograft recipients: Results at 2 1/2–6 years, Transplantation, 45, 380, 10.1097/00007890-198802000-00027 Kahan, 1987, Complications of cyclosporine-prednisone immunosuppression in 402 renal allograft recipients exclusively followed at a single center for from one to five years, Transplantation, 43, 197, 10.1097/00007890-198702000-00007 Klintmalm, 1984, Interstitial fibrosis in renal allografts after 12 to 46 months of cyclosporine treatment: Beneficial effect of low doses in early post-transplantation period, Lancet, 2, 950, 10.1016/S0140-6736(84)91166-8 Kupin, 1985, Sequential use of Minnesota antilymphoblast globulin and cyclosporine in cadaveric renal transplantation, Transplantation, 40, 601, 10.1097/00007890-198512000-00005 Landegren, 1982, Selective inhibition of human T-cell cytotoxicity at levels of target recognition for initiation of lysis by monoclonal OKT3 and Leu-2A antibodies, J Exp Med, 155, 1579, 10.1084/jem.155.5.1579 Manninen, 1987, The costs and outcomes of kidney transplantation according to initial immunosuppressive drug protocol, 269 Matas, 1988, Individualization of immediate post-transplant immunosuppression: The value of antilymphocyte globulin in patients with delayed graft function, Transplantation, 45, 406, 10.1097/00007890-198802000-00032 Matthews, 1988, 141 Merion, 1985, Delayed acute rejection episodes in cyclosporine-treated renal transplant recipients, Ann Surg, 201, 444, 10.1097/00000658-198504000-00007 Monaco, 1987, Use of Orthoclone OKT3 monoclonal antibody to reverse acute renal rejection unresponsive to treatment with conventional immunosuppressive regimens, Transplant Proc, 19, 28 Najarian, 1976, Seven years’ experience with antilymphoblast globulin for renal transplantation, Ann Surg, 184, 352, 10.1097/00000658-197609000-00013 Najarian, 1985, A single institution, randomized, prospective trial of cyclosporine versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients, Ann Surg, 201, 142, 10.1097/00000658-198502000-00003 Novick, 1983, A controlled, randomized, double-blind study of antilymphoblast globulin in cadaver renal transplantation, Transplantation, 35, 175, 10.1097/00007890-198302000-00013 Novick, 1986, The role of antilymphocyte globulin in cadaver renal transplantation, Transplant Proc, 18, 22 Oh, 1988, Increased infections associated with the use of OKT3 for treatment of steroid-resistant rejection in renal transplantation, Transplantation, 45, 68, 10.1097/00007890-198801000-00016 1988, Factors influencing early renal function in cadaveric kidney transplants: A case-control study, Transplantation, 45, 122, 10.1097/00007890-198801000-00027 1985, A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants, N Engl J Med, 313, 337, 10.1056/NEJM198508083130601 Sanfilippo, 1984, The detrimental effects of delayed graft function in cadaver donor renal transplantation, Transplantation, 38, 643, 10.1097/00007890-198412000-00019 Shaffer, 1987, Infectious complications with the use of cyclosporine versus azathioprine after cadaveric kidney transplantation, Am J Surg, 153, 381, 10.1016/0002-9610(87)90582-4 Sheil, 1973, Antilymphocyte globulin in patients with renal allografts from cadaveric donors: Late results of a controlled trial, Lancet, 2, 227, 10.1016/S0140-6736(73)93132-2 Simmons, 1970, Immunosuppressive assay of antilymphoblast globulin in man: Effect of dose, histocompatibility, and serologic response to horse gamma globulin, Surgery, 68, 62 Salapak, 1987, Triple and quadruple immunosuppressive therapy in organ transplantation, Lancet, 2, 958, 10.1016/S0140-6736(87)91434-6 Sommer, 1985, Three immediate post-renal transplant adjunct protocols combined with maintenance cyclosporine, Transplant Proc, 17, 1235 Sommer, 1987, Sequential antilymphoblast globulin and cyclosporine for renal transplantation, Transplantation, 43, 85, 10.1097/00007890-198701000-00019 1981, Current results and expectations of renal transplantation, JAMA, 246, 1330, 10.1001/jama.1981.03320120034022 Starzl, 1967, The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation, Surg Gynecol Obstet, 124, 301 Starzl, 1981, Cyclosporine A and steroid therapy in 66 cadaver kidney recipients, Surg Gynecol Obstet, 153, 486 Stratta, 1988, Cadaveric renal transplantation in the cyclosporine and OKT3 eras, Surgery, 104, 606 Stratta RJ, D’Alessandro AM, Armbrust MJ, et al: Sequential ALG/cyclosporine immunosuppression in cadaveric renal transplantation: Effect of duration of ALG therapy. Transplantation, in press Stratta, 1988, Kidney retransplantation in the cyclosporine era, Transplantation, 45, 40 Taylor, 1976, Canadian clinical trial of antilymphocyte globulin in human cadaver renal transplantation, Can Med Assoc J, 115, 1205 Thistlethwaite, 1987, OKT3 treatment of steroid-resistant renal allograft failure, Transplantation, 43, 176, 10.1097/00007890-198702000-00003 Tilney, 1984, Experience with cyclosporine and steroids in clinical renal transplantation, Ann Surg, 200, 605, 10.1097/00000658-198411000-00009 Tolkoff-Rubin, 1986, The impact of cyclosporine therapy on the occurrence of infection in the renal transplant recipient, Transplant Proc, 18, 168 Turcotte, 1973, Antilymphocyte globulin in renal transplant recipients: A clinical trial, Arch Surg, 106, 484, 10.1001/archsurg.1973.01350160102016 Van Buren, 1986, Cyclosporine: Progress, problems, and perspectives, Surg Clin North Am, 66, 435, 10.1016/S0039-6109(16)43931-9 Wechter, 1975, Extended treatment with antilymphocyte globulin (ATGAM) in renal allograft recipients, Transplantation, 28, 365, 10.1097/00007890-197911000-00003